Lauren Biscaldi, MS, Managing Editor

Calcitonin gene-related peptides are known to trigger vasodilation and inflammation.

Ustekinumab-ttwe, a biosimilar to ustekinumab (Stelara) is expected launch in the US in February 2025.

Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.

Previously, data from head-to-head trials of tirzepatide and semaglutide were not available.

Current recommendations suggest women receive the RSV vaccine between 32 and 36 weeks' gestational age.

Results of a new survey show that individuals with dry eye believe the condition is something “people must learn to live with.”

Donanemab-azbt was approved under the FDA's Fast Track Review, Priority Review, and Breakthrough Therapy designations.

The updates follow the Advisory Committee for Immunization Practice meeting held June 26 to 28, 2024.

Dive in and learn more about the answers to yesterday’s quiz.

The theme of this year’s National HIV Testing Day encourages individuals to self-test for HIV as a means of demonstrating their compassion for themselves.

Test your knowledge of migraine therapies.

A selection of studies presented at the American Diabetes Association 84th Scientific Sessions examined the use of CGM technology in type 2 diabetes.

Cases of Dengue virus—the most common global arboviral disease—are on the rise.

Access to diabetes self-management education and support services are crucial for improving diabetes outcomes.

Check out some of the latest research into diabetes medication options.

The Victoza generic is approved for use in adults and children aged 10 years and older.

Dive in and learn more about the answers to yesterday’s quiz.

Test your knowledge of different migraine triggers.

Two phase 3 clinical trials form the basis of a supplemental New Drug Application for this indication.

The vaccine covers 8 serotypes not currently covered by any FDA-approved pneumococcal vaccines.

The CDC released an alert encouraging pharmacists and providers to counsel patients around the harms of illegal stimulant medications.

As the opioid crisis and injection drug use continue, pharmacists can look to previous outbreaks to guide their responses to the HIV–injection drug use syndemic.

The vaccine, mRNA-1083, elicited noninferior responses vs individual COVID-19 and flu vaccinations.

Dive in and learn more about the answers to yesterday’s quiz.

Overdose deaths have decreased for the first time since 2018, but naloxone remains an important tool in fighting the opioid epidemic.

Test your knowledge different headache types.

Check out this list of resources to share with patients who are managing a migraine or other headache diagnosis.

Study results were promising, but larger studies are needed.

All Boehringer Ingelheim inhalers are included in the program and will be available for $35 per month for eligible patients.

mRESVIA is the first mRNA vaccine approved for a disease other than COVID-19.